Comparison of Large Language Models in Answering Immuno-Oncology Questions: A Cross-Sectional Study.
Giovanni Maria IannantuonoDara Bracken-ClarkeFatima KarzaiHyoyoung Choo-WosobaJames L GulleyCharalampos S FloudasPublished in: The oncologist (2024)
ChatGPT-4 and ChatGPT-3.5 are potentially powerful tools in immuno-oncology, whereas Google Bard demonstrated relatively poorer performance. However, the risk of inaccuracy or incompleteness in the responses was evident in all 3 LLMs, highlighting the importance of expert-driven verification of the outputs returned by these technologies.